The Valley Desk

LetterThe New England journal of medicinePublished

Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC. Reply

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Letter
Venue
The New England journal of medicine
Published
PubMed ID
41740051
Added to directory
Source checked

Report a correction or request removal